Operating Margin of CytomX Therapeutics, Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
CytomX Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • CytomX Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was 20%, a 286% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Operating Margin for 2024 was 18%.
  • CytomX Therapeutics, Inc. annual Operating Margin for 2023 was -6.4%, a 97% increase from 2022.
  • CytomX Therapeutics, Inc. annual Operating Margin for 2022 was -191%, a 39% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

CytomX Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 20% +15% +286% 01 Jul 2025 30 Sep 2025
Q2 2025 31% +26% +539% 01 Apr 2025 30 Jun 2025
Q1 2025 24% +15% +168% 01 Jan 2025 31 Mar 2025
Q4 2024 18% +25% 01 Oct 2024 31 Dec 2024
Q3 2024 5.3% +22% 01 Jul 2024 30 Sep 2024
Q2 2024 4.8% +65% 01 Apr 2024 30 Jun 2024
Q1 2024 9.1% +120% 01 Jan 2024 31 Mar 2024
Q4 2023 -6.4% +184% +97% 01 Oct 2023 31 Dec 2023
Q3 2023 -16% +602% +97% 01 Jul 2023 30 Sep 2023
Q2 2023 -61% +415% +87% 01 Apr 2023 30 Jun 2023
Q1 2023 -111% +300% +73% 01 Jan 2023 31 Mar 2023
Q4 2022 -191% +120% +39% 01 Oct 2022 31 Dec 2022
Q3 2022 -618% -311% -101% 01 Jul 2022 30 Sep 2022
Q2 2022 -475% -187% -65% 01 Apr 2022 30 Jun 2022
Q1 2022 -410% -128% -45% 01 Jan 2022 31 Mar 2022
Q4 2021 -311% -193% -164% 01 Oct 2021 31 Dec 2021
Q3 2021 -307% -105% -52% 01 Jul 2021 30 Sep 2021
Q2 2021 -288% -59% -26% 01 Apr 2021 30 Jun 2021
Q1 2021 -283% -5.5% -2% 01 Jan 2021 31 Mar 2021
Q4 2020 -118% +408% +78% 01 Oct 2020 31 Dec 2020
Q3 2020 -202% -38% -23% 01 Jul 2020 30 Sep 2020
Q2 2020 -229% -74% -48% 01 Apr 2020 30 Jun 2020
Q1 2020 -277% -172% -163% 01 Jan 2020 31 Mar 2020
Q4 2019 -526% -395% -302% 01 Oct 2019 31 Dec 2019
Q3 2019 -164% -93% -131% 01 Jul 2019 30 Sep 2019
Q2 2019 -155% -107% -226% 01 Apr 2019 30 Jun 2019
Q1 2019 -105% -34% -47% 01 Jan 2019 31 Mar 2019
Q4 2018 -131% -66% -103% 01 Oct 2018 31 Dec 2018
Q3 2018 -71% +46% +39% 01 Jul 2018 30 Sep 2018
Q2 2018 -47% +162% +77% 01 Apr 2018 30 Jun 2018
Q1 2018 -72% +141% +66% 01 Jan 2018 31 Mar 2018
Q4 2017 -65% +332% +84% 01 Oct 2017 31 Dec 2017
Q3 2017 -117% +412% +78% 01 Jul 2017 30 Sep 2017
Q2 2017 -210% +366% +64% 01 Apr 2017 30 Jun 2017
Q1 2017 -213% +331% +61% 01 Jan 2017 31 Mar 2017
Q4 2016 -396% +34% +8% 01 Oct 2016 31 Dec 2016
Q3 2016 -529% 01 Jul 2016 30 Sep 2016
Q2 2016 -576% 01 Apr 2016 30 Jun 2016
Q1 2016 -543% 01 Jan 2016 31 Mar 2016
Q4 2015 -431% 01 Oct 2015 31 Dec 2015

CytomX Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 18% +25% 01 Jan 2024 31 Dec 2024
2023 -6.4% +184% +97% 01 Jan 2023 31 Dec 2023
2022 -191% +120% +39% 01 Jan 2022 31 Dec 2022
2021 -311% -193% -164% 01 Jan 2021 31 Dec 2021
2020 -118% +408% +78% 01 Jan 2020 31 Dec 2020
2019 -526% -395% -302% 01 Jan 2019 31 Dec 2019
2018 -131% -66% -103% 01 Jan 2018 31 Dec 2018
2017 -65% +332% +84% 01 Jan 2017 31 Dec 2017
2016 -396% +34% +8% 01 Jan 2016 31 Dec 2016
2015 -431% +156% +27% 01 Jan 2015 31 Dec 2015
2014 -586% +1098% +65% 01 Jan 2014 31 Dec 2014
2013 -1684% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.